Login to Your Account

Medivir Moves to Commercialize in Co-Promotion Deal with GSK

By Cormac Sheridan

Wednesday, April 16, 2008
Medivir AB took a first step toward building a commercial organization by entering a co-promotion agreement with London-based GlaxoSmithKline plc's Swedish subsidiary. The deal enables the company to market in Sweden a portfolio of dermatology and infectious disease products, as well as the smoking-cessation aid Zyban. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription